Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing

Erik Gatenholm

๐Ÿ‘ค Speaker
171 total appearances

Appearances Over Time

Podcast Appearances

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

I'm now at $20,000 per top.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

Five and six million.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

He is hell-bent on global domination.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

We just broke our 100,000-unit soul mark.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

All right.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

So it was a it was a company based on a technology that was licensed out of Virginia Tech University.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

I was a student at BT, started in 2008 in business management.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

And I decided to start a company around a technology where we developed medical devices based on bacterial cellulose, which is basically a novel material, a very innovative material that's been used for basically hundreds of years for desserts, actually, in the Philippines.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

And now we decided to take it to the market for medical purposes.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

So I was actually, the company still exists.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

I made an exit myself to the other shareholders.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

I was bought out.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

It was a decent exit.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

And I decided to, actually my mentors and I, we decided to, I need to go back.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

I need to go back, get my master's.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

The plan was to come back and continue with the business after two years.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

But then I got involved in this and it's just, this thing just blew up.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

I sold a portion so they could take majority of it.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

I felt that this was basically required to take the business to the next step.

SaaS Interviews with CEOs, Startups, Founders
He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241

The company was in a preclinical stage, meaning we had products already in preclinical development.

โ† Previous Page 1 of 9 Next โ†’